Email this article Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs1
- Authors: Aisanov ZR1,2, Kalmanova EN1,2, Chuchalin AG1,2
-
Affiliations:
- НИИ пульмонологии МЗ
- СР РФ, Москва
- Issue: Vol 79, No 12 (2004)
- Pages: 81-83
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/29976
- ID: 29976
Cite item
Full Text
Abstract
Keywords
About the authors
Z R Aisanov
НИИ пульмонологии МЗ; СР РФ, МоскваНИИ пульмонологии МЗ; СР РФ, Москва
E N Kalmanova
НИИ пульмонологии МЗ; СР РФ, МоскваНИИ пульмонологии МЗ; СР РФ, Москва
A G Chuchalin
НИИ пульмонологии МЗ; СР РФ, МоскваНИИ пульмонологии МЗ; СР РФ, Москва
References
- Reynolds R. J., Buford J. G., George R. B. Treating asthma and COPD in patients with heart disease. J. Respir. Dis. 1982; 3: 41.
- Behar S., Panosh A., Rekher-Reiss H. et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am. J. Med. 1992; 93: 637.
- Shih H. Т., Webb С. R., Conway W. A. et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94: 44.
- Jousilahti P., Vartiainen E., Tuomilehto J. et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348: 567.
- Fuso L., Incalz R. A., Pistelli R. et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am. J. Med. 1995; 98: 272.
- Козлова Л. И., Бузунов Р. В., Чучалин А. Г. Хроническая обструктивная болезнь легкого у больных с ишемической болезнью сердца: 15-летнее исследование. Тер. арх. 2001; 73 (3, прил. 10): 11-21.
- Summers R. J., Molnaar P., Russell F. et al. Coexistence and localization of beta 1- and beta 2-adrenoceptors in the human heart. Eur. Heart J. 1989; 10 (suppl. B): 11-21.
- Neville E., Corns P. A., Vivian J. et al. Nebulised salbutamol and angina. Br. Med. J. 1982; 285 (6344): 796-797.
- Au D. H., Curtis J. R., Every N. R. et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest 2002: 12! (3): 846-851.
- Oga Т., Nishimura K., Tsukino M. et al. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Chest 2003; 123 (6): 1810- 1816.
- Langley S. J., Towse L., Kesten S., Calverley P. M. Heart rate and rhythm analysis from holter monitoring in COPD patients receiving tiotropium. A. J. Respir. Crit. Care Med. 2002; 165 (8): A592.
- ZuWallack R., Morganroth J., Lanes S., Kesten S. Electrocardiographic evaluations in COPD patients treated with tiotropium in 1-year clinical trials. Am. J. Respir. Crit. Care Med. 2003; 167 (7): A94.
- O'Donnell D. E., Helgo Magnussen H., Gerken F. et al. Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur. Respir. J. 2002; 19 (suppl.): P1826.
- O'Donnell D. E., Magnussen H., Gerken F. et al. Cardiovascular evaluation of tiotropium during constant work rate exercise in COPD. Eur. Respir. J. 2003; 22 (suppl. 45): 49s.
